• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Mahesh Pavithra

    1/30/26 4:14:58 PM ET
    $INNV
    Medical/Nursing Services
    Health Care
    Get the next $INNV alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    MAHESH PAVITHRA

    (Last) (First) (Middle)
    8950 E LOWRY BLVD

    (Street)
    DENVER CO 80230

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    01/28/2026
    3. Issuer Name and Ticker or Trading Symbol
    InnovAge Holding Corp. [ INNV ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Exhibit 24 - Power of Attorney
    No securities are beneficially owned.
    /s/ Nicole D'Amato, by Power of Attorney 01/30/2026
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $INNV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INNV

    DatePrice TargetRatingAnalyst
    9/18/2025$5.00Underweight
    Analyst
    12/17/2024$5.00Neutral → Underweight
    Analyst
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/16/2022$6.00 → $5.00Outperform → Neutral
    Robert W. Baird
    4/20/2022$4.00 → $5.00Neutral → Underweight
    Piper Sandler
    1/10/2022$8.00 → $5.00Neutral
    Citigroup
    12/28/2021$15.00 → $4.00Buy → Neutral
    Goldman Sachs
    12/27/2021$22.00 → $6.50Overweight → Equal-Weight
    Barclays
    More analyst ratings

    $INNV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Traynor Sean

    3 - InnovAge Holding Corp. (0001834376) (Issuer)

    1/30/26 4:15:41 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Mahesh Pavithra

    3 - InnovAge Holding Corp. (0001834376) (Issuer)

    1/30/26 4:14:58 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    CHIEF EXECUTIVE OFFICER Blair Patrick T covered exercise/tax liability with 5,054 shares, decreasing direct ownership by 0.71% to 709,072 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    12/2/25 4:29:44 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on InnovAge with a new price target

    Analyst resumed coverage of InnovAge with a rating of Underweight and set a new price target of $5.00

    9/18/25 8:43:47 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge downgraded by Analyst with a new price target

    Analyst downgraded InnovAge from Neutral to Underweight and set a new price target of $5.00

    12/17/24 8:06:24 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    KeyBanc Capital Markets initiated coverage on InnovAge

    KeyBanc Capital Markets initiated coverage of InnovAge with a rating of Sector Weight

    10/11/24 7:47:55 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    SEC Filings

    View All

    SEC Form 10-Q filed by InnovAge Holding Corp.

    10-Q - InnovAge Holding Corp. (0001834376) (Filer)

    2/3/26 5:09:29 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Holding Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - InnovAge Holding Corp. (0001834376) (Filer)

    2/3/26 4:06:52 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Holding Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InnovAge Holding Corp. (0001834376) (Filer)

    1/29/26 8:09:34 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Proven Senior Care Model Takes Center Stage at the Capitol

    DENVER, Feb. 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), a leading Program of All-Inclusive Care for the Elderly (PACE) provider, in partnership with LeadingAge Colorado, met with state lawmakers today at the Colorado State Capitol to underscore the importance of protecting and strengthening care for Colorado's aging population, including through PACE. Seniors enrolled in InnovAge Colorado PACE met with several lawmakers to share firsthand how the program delivers comprehensive, person-centered care that allows older adults to remain living safely and independently in their homes and communities. Representatives from InnovAge's six Colorado PACE centers

    2/5/26 8:45:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025

    DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal second quarter ended December 31, 2025. "InnovAge delivered strong operating and financial results this quarter, reflecting continued progress in building a scalable, high-quality PACE platform," said Patrick Blair, CEO. "Our performance is rooted in disciplined execution and a care model that prioritizes clinical outcomes, participant experience, and respon

    2/3/26 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Expands Board with Appointment of Two Directors

    DENVER, Jan. 29, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the appointment of Pavithra Mahesh and Sean Traynor to its Board of Directors (the "Board"), effective immediately. Ms. Mahesh will serve as a Class III director and as a member of the Quality and Compliance Committee, and Mr. Traynor will serve as a Class I director and as a member of the Compensation, Nominating and Governance Committee. In connection with these appointments, the Board

    1/29/26 8:00:00 AM ET
    $AMSF
    $INNV
    Property-Casualty Insurers
    Finance
    Medical/Nursing Services
    Health Care

    $INNV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zoretic Richard C bought $173,307 worth of shares (42,715 units at $4.06), increasing direct ownership by 166% to 68,494 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    5/30/25 5:08:25 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    Director Zoretic Richard C bought $12,308 worth of shares (3,045 units at $4.04), increasing direct ownership by 13% to 25,779 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    5/23/25 4:31:41 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    Director Zoretic Richard C bought $12,317 worth of shares (2,893 units at $4.26), increasing direct ownership by 15% to 22,734 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    5/20/25 8:57:01 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Financials

    Live finance-specific insights

    View All

    InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025

    DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal second quarter ended December 31, 2025. "InnovAge delivered strong operating and financial results this quarter, reflecting continued progress in building a scalable, high-quality PACE platform," said Patrick Blair, CEO. "Our performance is rooted in disciplined execution and a care model that prioritizes clinical outcomes, participant experience, and respon

    2/3/26 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge to Announce Fiscal Second Quarter 2026 Financial Results and Host Conference Call Tuesday, February 3, 2026

    DENVER, Jan. 21, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2026 fiscal second quarter financial results on Tuesday, February 3, 2026, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be ava

    1/21/26 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2025

    DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal first quarter ended September 30, 2025. "We're off to a strong start in fiscal 2026," said Patrick Blair, CEO. "Our results reflect disciplined execution, continued investment in our people and technology, and growing momentum in the business. We remain focused on delivering high-quality, cost-effective care to more seniors while building the foundation for

    11/4/25 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Leadership Updates

    Live Leadership Updates

    View All

    InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer

    DENVER, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Paul Taheri, MD, MBA as its Chief Medical Officer, effective November 3, 2025. Dr. Paul Taheri, a board-certified trauma surgeon, brings more than 30 years of healthcare leadership to InnovAge. He has served as a Clinical Quality Advisor to Welsh, Carson, Anderson & Stowe, a role he has held since 2019. Dr. Taheri previously served as CEO and Deputy Dean for Clinical Affairs at the Yale School of

    11/3/25 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Appoints Meredith Delk as Executive Vice President and Chief Administrative Officer

    DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Meredith Delk as its Executive Vice President and Chief Administrative Officer, effective September 30, 2025. Meredith Delk brings over 20 years of healthcare leadership experience to InnovAge, and until recently led one of the largest Medicaid PBMs in the country. In this newly created role at InnovAge, Delk will lead InnovAge's Pharmacy Solutions, Behavioral Health, Home Health, and Therapy ser

    9/23/25 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services

    DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Michael Scarbrough as its new President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, effective November 4th. Mr. Scarbrough joins InnovAge's executive leadership team as Christine Bent steps down from the role of COO to explore new career opportunities. Scarbrough will also assume the role of President as the Company separates the positions of President and CEO to better enable exec

    11/4/24 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by InnovAge Holding Corp.

    SC 13G/A - InnovAge Holding Corp. (0001834376) (Subject)

    11/13/24 7:44:57 PM ET
    $INNV
    Medical/Nursing Services
    Health Care